Bruker Corporation Company Profile (NASDAQ:BRKR)

About Bruker Corporation (NASDAQ:BRKR)

Bruker Corporation logoBruker Corporation designs and manufactures scientific instruments, and analytical and diagnostic solutions. Its segments include the Bruker BioSpin Group; the Bruker Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID) Group; the Bruker Nano Group, and the Bruker Energy & Supercon Technologies (BEST) Segment. The Bruker BioSpin Group segment designs, manufactures and distributes enabling life science tools. The Bruker CALID segment designs, manufactures and distributes life science mass spectrometry instruments that can be integrated and used along with other sample preparation or chromatography instruments, as well as chemical, biological, radiological, nuclear and explosive detection products. The Bruker Nano segment designs, manufactures and distributes spectroscopy and microscopy instruments. The BEST segment develops and manufactures superconducting and non-superconducting materials and devices. It also focuses on nanomechanical testing instruments.

Industry, Sector and Symbol:
  • Sector: Computer and Technology
  • Industry: Advanced Medical Equipment & Technology
  • Sub-Industry: Life Sciences Tools & Services
  • Symbol: NASDAQ:BRKR
  • CUSIP: 11679410
  • Web:
  • Market Cap: $4.74899 billion
  • Outstanding Shares: 158,701,000
Average Prices:
  • 50 Day Moving Avg: $29.93
  • 200 Day Moving Avg: $27.63
  • 52 Week Range: $19.59 - $30.97
  • Trailing P/E Ratio: 30.45
  • Foreward P/E Ratio: 24.23
  • P/E Growth: 3.64
Sales & Book Value:
  • Annual Revenue: $1.66 billion
  • Price / Sales: 2.92
  • Book Value: $4.76 per share
  • Price / Book: 6.41
  • Annual Dividend: $0.16
  • Dividend Yield: 0.5%
  • EBITDA: $275 million
  • Net Margins: 9.65%
  • Return on Equity: 26.66%
  • Return on Assets: 10.47%
  • Debt-to-Equity Ratio: 0.56%
  • Current Ratio: 2.63%
  • Quick Ratio: 1.61%
  • Average Volume: 486,326 shs.
  • Beta: 1.09
  • Short Ratio: 5.01

Frequently Asked Questions for Bruker Corporation (NASDAQ:BRKR)

What is Bruker Corporation's stock symbol?

Bruker Corporation trades on the NASDAQ under the ticker symbol "BRKR."

How often does Bruker Corporation pay dividends? What is the dividend yield for Bruker Corporation?

Bruker Corporation announced a quarterly dividend on Monday, August 14th. Stockholders of record on Tuesday, September 5th will be paid a dividend of $0.04 per share on Friday, September 22nd. This represents a $0.16 annualized dividend and a dividend yield of 0.52%. The ex-dividend date is Thursday, August 31st. View Bruker Corporation's Dividend History.

How will Bruker Corporation's stock buyback program work?

Bruker Corporation announced that its Board of Directors has initiated a stock buyback program on Sunday, June 4th 2017, which authorizes the company to buyback $225,000,000.00 in shares, according to EventVestor. This buyback authorization authorizes the company to purchase shares of its stock through open market purchases. Stock buyback programs are generally an indication that the company's leadership believes its shares are undervalued.

How were Bruker Corporation's earnings last quarter?

Bruker Corporation (NASDAQ:BRKR) released its earnings results on Thursday, August, 3rd. The company reported $0.23 EPS for the quarter, topping analysts' consensus estimates of $0.20 by $0.03. The business earned $414.90 million during the quarter, compared to analysts' expectations of $384.75 million. Bruker Corporation had a net margin of 9.65% and a return on equity of 26.66%. Bruker Corporation's revenue was up 11.6% on a year-over-year basis. During the same quarter last year, the company earned $0.20 earnings per share. View Bruker Corporation's Earnings History.

When will Bruker Corporation make its next earnings announcement?

Bruker Corporation is scheduled to release their next quarterly earnings announcement on Thursday, November, 2nd 2017. View Earnings Estimates for Bruker Corporation.

What guidance has Bruker Corporation issued on next quarter's earnings?

Bruker Corporation updated its FY17 earnings guidance on Thursday, August, 3rd. The company provided earnings per share (EPS) guidance of $1.08 to $1.12 for the period, compared to the Thomson Reuters consensus estimate of $1.10. The company issued revenue guidance of +4.5-6% to $1.68-1.71 billion, compared to the consensus revenue estimate of $1.68 billion.

Where is Bruker Corporation's stock going? Where will Bruker Corporation's stock price be in 2017?

13 analysts have issued twelve-month target prices for Bruker Corporation's stock. Their forecasts range from $20.00 to $30.00. On average, they expect Bruker Corporation's share price to reach $26.00 in the next year. View Analyst Ratings for Bruker Corporation.

What are analysts saying about Bruker Corporation stock?

Here are some recent quotes from research analysts about Bruker Corporation stock:

  • 1. According to Zacks Investment Research, "Bruker’s latest spree of product development is encouraging, the latest launch being the AVANCE NEO platform, a next-generation NMR console. The company’s strategic acquisition activity also encourages us. Also the cost-reduction action previously adopted by the company in its Nano-surfaces business played its role suitably. The company's solid cash balance on the back of improved free cash flow is indicative of strong fundamentals. Above all, the company’s raised revenue guidance also holds optimism indicating promising performance ahead. On the flip side, over the last one year, Bruker is trading below the Zacks categorized Instruments-Scientific industry. We are also discouraged with the company's year-over-year decline in organic revenues in the last reported first quarter. We are also concerned about currency fluctuations, competitive landscape and macroeconomic headwinds which are the major woes for Bruker." (7/6/2017)
  • 2. Jefferies Group LLC analysts commented, "4Q16 EPS walloped consensus (+9c / +4c operational), while the initial 2017 EPS outlook bracketed consensus. Commentary pointed to further signs of endmarket stability as EU orders turned positive in 4Q (first time all yr). Net-net, BRKR is managing the P&L better than it ever has, and with end-mkts steadily improving, we like the risk/reward & see room for upside. We modestly raise our '17/18 EPS by +1c/+5c (to $1.08/$1.30)." (2/14/2017)
  • 3. Evercore ISI analysts commented, "Bruker continues to execute well across its business, delivering on impressive GM expansion, while continuing OpEx rationalization and stepping up capital allocation. Thus in terms of what management can control they are doing an excellent job and certainly have delivered much of what shareholders demanded several years ago. That being said end markets remain not fully cooperative, and while EU academic has improved it is off of depressed levels. Given this dynamic core growth remains constrained and in a year where the growth comparable is tough due to tax savings the current outlook for EPS upside is mixed. With shares trading north of 20x we contend that visibility back to 3-5% core growth must improve, and we look for further check points from management in the first part of 2017. We think if bookings momentum continues to accelerate over the next few quarters that will be the signal to get incrementally constructive on shares. Therefore we await additional proof points and in the near-term remain on the sidelines." (2/14/2017)
  • 4. Cantor Fitzgerald analysts commented, "CytoSorbents announced that the company has now received a permanent, dedicated, reimbursement procedure code for CytoSorb in Germany." This is positive news." (12/7/2016)

Who are some of Bruker Corporation's key competitors?

Who are Bruker Corporation's key executives?

Bruker Corporation's management team includes the folowing people:

  • Frank H. Laukien Ph.D., Chairman of the Board, President, Chief Executive Officer
  • Anthony L. Mattacchione, Chief Financial Officer, Senior Vice President
  • Juergen Srega, President of Bruker CALID Group and Bruker Daltonics Division
  • Mark Robert Munch Ph.D., Executive Vice President - President of Bruker Nano Group and Bruker Nano Surfaces Division
  • William A. Linton, Lead Independent Director
  • Joerg C. Laukien, Director
  • Cynthia M. Friend Ph.D., Independent Director
  • Marc A. Kastner Ph.D., Independent Director
  • Richard D. Kniss, Independent Director

Who owns Bruker Corporation stock?

Bruker Corporation's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Fisher Asset Management LLC (0.09%). Company insiders that own Bruker Corporation stock include Frank H Laukien, Ingen Chris Van, Joerg C Laukien, Mark Munch, Richard A Packer, Richard Kniss and Wolf-Dieter Emmerich. View Institutional Ownership Trends for Bruker Corporation.

Who bought Bruker Corporation stock? Who is buying Bruker Corporation stock?

Bruker Corporation's stock was acquired by a variety of institutional investors in the last quarter, including Fisher Asset Management LLC. Company insiders that have bought Bruker Corporation stock in the last two years include Frank H Laukien and Richard A Packer. View Insider Buying and Selling for Bruker Corporation.

How do I buy Bruker Corporation stock?

Shares of Bruker Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Bruker Corporation's stock price today?

One share of Bruker Corporation stock can currently be purchased for approximately $30.53.

MarketBeat Community Rating for Bruker Corporation (NASDAQ BRKR)
Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  284 (Vote Outperform)
Underperform Votes:  341 (Vote Underperform)
Total Votes:  625
MarketBeat's community ratings are surveys of what our community members think about Bruker Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Bruker Corporation (NASDAQ:BRKR) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 2 Sell Ratings, 8 Hold Ratings, 3 Buy Ratings
Consensus Rating:Hold (Score: 2.08)
Consensus Price Target: $26.00 (14.82% downside)
Consensus Price Target History for Bruker Corporation (NASDAQ:BRKR)
Price Target History for Bruker Corporation (NASDAQ:BRKR)
Analysts' Ratings History for Bruker Corporation (NASDAQ:BRKR)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
9/26/2017Goldman Sachs Group IncReiterated RatingSell -> Sell$24.00LowView Rating Details
7/17/2017Barclays PLCReiterated RatingEqual Weight$26.00 -> $30.00LowView Rating Details
7/14/2017Cowen and CompanyReiterated RatingHold$29.00LowView Rating Details
7/12/2017Wells Fargo & CompanyDowngradeMarket Perform -> UnderperformMediumView Rating Details
5/15/2017Jefferies Group LLCReiterated RatingBuy$29.00N/AView Rating Details
5/15/2017Deutsche Bank AGBoost Price TargetHold$25.00 -> $27.00N/AView Rating Details
4/27/2017Cleveland ResearchUpgradeNeutral -> BuyHighView Rating Details
3/27/2017Janney Montgomery ScottDowngradeBuy -> NeutralLowView Rating Details
2/15/2017BTIG ResearchReiterated RatingHoldN/AView Rating Details
2/14/2017Cantor FitzgeraldSet Price TargetBuy$28.00N/AView Rating Details
2/14/2017Evercore ISIBoost Price TargetHold$23.50 -> $26.00N/AView Rating Details
12/14/2016J P Morgan Chase & CoDowngradeOverweight -> Neutral$23.00 -> $20.00N/AView Rating Details
11/10/2016Leerink SwannInitiated CoverageMarket Perform$21.00N/AView Rating Details
8/3/2016Morgan StanleySet Price TargetHold$23.00N/AView Rating Details
8/3/2016MizuhoLower Price TargetNeutral$28.00 -> $23.00N/AView Rating Details
4/5/2016Bank of America CorporationDowngradeNeutral -> UnderperformN/AView Rating Details
3/14/2016Stifel NicolausBoost Price TargetBuy$25.00 -> $32.00N/AView Rating Details
1/6/2016Avondale PartnersInitiated CoverageMarket Perform$26.00N/AView Rating Details
(Data available from 10/21/2015 forward)


Earnings History for Bruker Corporation (NASDAQ:BRKR)
Earnings by Quarter for Bruker Corporation (NASDAQ:BRKR)
Earnings History by Quarter for Bruker Corporation (NASDAQ BRKR)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/2/2017$0.27N/AView Earnings Details
8/3/2017Q2 2017$0.20$0.23$384.75 million$414.90 millionViewN/AView Earnings Details
5/3/2017Q1 2017$0.19$0.19$372.59 million$384.90 millionViewN/AView Earnings Details
2/13/2017Q416$0.37$0.46$464.49 million$470.30 millionViewN/AView Earnings Details
11/2/2016Q316$0.20$0.32$394.14 million$393.90 millionViewN/AView Earnings Details
8/2/2016Q216$0.20$0.20$409.57 million$371.70 millionViewN/AView Earnings Details
5/4/2016Q116$0.15$0.21$360.37 million$375.40 millionViewN/AView Earnings Details
2/10/2016Q415$0.27$0.38$469.98 million$478.20 millionViewN/AView Earnings Details
11/4/2015Q315$0.13$0.19$373.65 million$396.10 millionViewN/AView Earnings Details
8/5/2015Q215$0.17$0.19$391.87 million$396.00 millionViewN/AView Earnings Details
5/6/2015Q115$0.10$0.14$369.80 million$353.50 millionViewN/AView Earnings Details
2/19/2015Q414$0.29$0.30$515.50 million$508.00 millionViewN/AView Earnings Details
11/6/2014Q314$0.15$0.14$436.30 million$419.80 millionViewN/AView Earnings Details
8/6/2014Q214$0.19$0.21$457.90 million$457.40 millionViewN/AView Earnings Details
5/7/2014Q114$0.09$0.11$402.04 million$423.70 millionViewN/AView Earnings Details
2/18/2014Q413$0.22$0.31$452.14 million$552.10 millionViewListenView Earnings Details
11/1/2013Q313$0.22$0.20$452.40 million$439.00 millionViewListenView Earnings Details
7/31/2013Q2 2013$0.14$0.18$426.39 million$454.90 millionViewListenView Earnings Details
5/2/2013Q1 2013$0.14$0.08$416.76 million$393.40 millionViewListenView Earnings Details
2/19/2013Q4 2012$0.24$0.28$483.65 million$517.30 millionViewListenView Earnings Details
11/5/2012Q312$0.15$0.28$421.39 million$447.80 millionViewN/AView Earnings Details
7/31/2012$0.12$0.12ViewN/AView Earnings Details
5/1/2012$0.12$0.14ViewN/AView Earnings Details
2/22/2012$0.29$0.31ViewN/AView Earnings Details
10/27/2011$0.22$0.23ViewN/AView Earnings Details
8/3/2011$0.21$0.20ViewN/AView Earnings Details
4/28/2011$0.15$0.14ViewN/AView Earnings Details
2/23/2011$0.27$0.27ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Bruker Corporation (NASDAQ:BRKR)
2017 EPS Consensus Estimate: $1.09
2018 EPS Consensus Estimate: $1.29
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20173$0.18$0.21$0.19
Q2 20173$0.17$0.21$0.19
Q3 20173$0.25$0.30$0.27
Q4 20173$0.42$0.47$0.44
Q1 20182$0.22$0.30$0.26
Q2 20182$0.26$0.32$0.29
Q3 20182$0.32$0.33$0.33
Q4 20182$0.37$0.45$0.41
(Data provided by Zacks Investment Research)


Current Dividend Information for Bruker Corporation (NASDAQ:BRKR)
Most Recent Dividend:9/22/2017
Annual Dividend:$0.16
Dividend Yield:0.52%
Payout Ratio:16.00% (Trailing 12 Months of Earnings)
14.29% (Based on This Year's Estimates)
12.70% (Based on Next Year's Estimates)
Dividend Payments by Quarter for Bruker Corporation (NASDAQ:BRKR)

Dividend History by Quarter for Bruker Corporation (NASDAQ BRKR)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Bruker Corporation (NASDAQ:BRKR)
Insider Ownership Percentage: 35.20%
Institutional Ownership Percentage: 65.42%
Insider Trades by Quarter for Bruker Corporation (NASDAQ:BRKR)
Institutional Ownership by Quarter for Bruker Corporation (NASDAQ:BRKR)
Insider Trades by Quarter for Bruker Corporation (NASDAQ:BRKR)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/13/2017Mark MunchVPSell21,061$29.97$631,198.17View SEC Filing  
8/10/2017Frank H LaukienCEOBuy2,335$27.39$63,955.65View SEC Filing  
6/14/2017Ingen Chris VanDirectorSell19,900$28.03$557,797.00View SEC Filing  
6/13/2017Richard KnissDirectorSell24,000$28.23$677,520.00View SEC Filing  
6/8/2017Mark MunchVPSell73,724$27.62$2,036,256.88View SEC Filing  
5/19/2017Frank H LaukienCEOBuy3,200$26.13$83,616.00View SEC Filing  
5/18/2017Frank H LaukienCEOBuy73,000$26.22$1,914,060.00View SEC Filing  
5/16/2017Frank H LaukienCEOBuy1,920$25.88$49,689.60View SEC Filing  
3/17/2017Frank H LaukienCEOBuy4,300$23.34$100,362.00View SEC Filing  
3/13/2017Frank H LaukienCEOBuy2,300$23.74$54,602.00View SEC Filing  
12/15/2016Frank H LaukienCEOBuy4,725$21.22$100,264.50View SEC Filing  
12/13/2016Ingen Chris VanDirectorSell20,000$22.29$445,800.00View SEC Filing  
11/25/2016Frank H LaukienCEOBuy2,124$22.90$48,639.60View SEC Filing  
8/10/2016Richard A PackerDirectorBuy10,000$21.97$219,700.00View SEC Filing  
8/5/2016Frank H LaukienCEOBuy4,500$22.17$99,765.00View SEC Filing  
6/14/2016Frank H LaukienCEOBuy4,174$23.95$99,967.30View SEC Filing  
6/6/2016Joerg C LaukienDirectorSell2,000,000$25.65$51,300,000.00View SEC Filing  
5/9/2016Wolf-Dieter EmmerichDirectorSell21,000$27.35$574,350.00View SEC Filing  
6/15/2015Frank H LaukienCEOBuy1,000,000$19.50$19,500,000.00View SEC Filing  
6/11/2015Frank H LaukienCEOBuy5,901$20.31$119,849.31View SEC Filing  
6/11/2015Stephen W FesikDirectorSell15,000$20.48$307,200.00View SEC Filing  
3/17/2015Charles F Wagner JrCFOSell19,000$18.97$360,430.00View SEC Filing  
3/5/2015Richard A PackerDirectorBuy15,000$19.00$285,000.00View SEC Filing  
2/25/2015Frank H LaukienCEOBuy5,271$18.95$99,885.45View SEC Filing  
12/14/2012Frank H LaukienCEOBuy50,000$14.68$734,000.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Bruker Corporation (NASDAQ:BRKR)
Latest Headlines for Bruker Corporation (NASDAQ:BRKR)
DateHeadline logoComparing Bruker Corporation (BRKR) and Accuray (ARAY) - October 21 at 4:24 AM logoBruker Announces Date and Time of Third Quarter 2017 Earnings Release and Webcast - October 16 at 5:30 PM logoContrasting Bruker Corporation (BRKR) & Its Competitors - October 12 at 2:26 AM logoBruker Corporation (BRKR) Given Consensus Rating of "Hold" by Analysts - October 12 at 12:48 AM logoFeatured Company News - Bruker Introduces Additional Key Products for Diagnosis and Susceptibility Testing of Invasive Fungal Diseases - October 9 at 5:30 PM logoBruker Introduces Additional Key Products for Diagnosis and Susceptibility Testing of Invasive Fungal Diseases (IFD) into European Clinical Microbiology Markets - October 6 at 5:02 PM logoAccuray (ARAY) vs. Bruker Corporation (BRKR) Financial Comparison - October 5 at 4:50 PM logoElectronic Equipment Stocks: What Best Wealth-Builders Now? - October 3 at 4:33 PM logoBruker Corporation's (BRKR) Sell Rating Reaffirmed at Goldman Sachs Group, Inc. (The) - October 1 at 11:34 PM logoIs Bruker Corporation’s (BRKR) ROE Of 22.57% Sustainable? - September 30 at 6:20 PM logoBruker Announces Acquisition of MERLIN to Add Selected Antibiotic Resistance and Susceptibility Testing to its MALDI Biotyper® Microbial Identification Platform - September 26 at 8:20 AM logoBruker Corp. : BRKR-US: Dividend Analysis : September 05th, 2017 (record date) : By the numbers : September 25, 2017 - September 25 at 8:00 PM logoDanaher Corporation (DHR) vs. Bruker Corporation (BRKR) Financial Comparison - September 23 at 8:32 PM logo Brokerages Anticipate Bruker Corporation (BRKR) to Post $0.27 EPS - September 19 at 4:12 AM logoBruker Launches the timsTOF™ Pro Mass Spectrometer to Enable the Revolutionary PASEF Method for Next-Generation Proteomics - September 18 at 5:05 PM logoBruker Corporation (BRKR) Receives Consensus Recommendation of "Hold" from Brokerages - September 17 at 12:52 AM logoBruker Corporation (BRKR) VP Mark Munch Sells 21,061 Shares - September 14 at 4:32 PM logoWhy Is Bruker (BRKR) Up 2.3% Since the Last Earnings Report? - September 5 at 6:19 PM logoBruker Corporation to Present at the 15th Annual Morgan Stanley Global Healthcare Conference - September 5 at 6:19 PM logoBruker Corporation (BRKR) Expected to Announce Quarterly Sales of $414.24 Million - September 2 at 7:30 AM logoBruker Corp. :BRKR-US: Earnings Analysis: Q2, 2017 By the Numbers : September 1, 2017 - September 1 at 5:03 PM logoBruker Corp. breached its 50 day moving average in a Bullish Manner : BRKR-US : August 23, 2017 - August 23 at 4:53 PM logoBruker Corporation (BRKR) Receives Average Rating of "Hold" from Brokerages - August 23 at 12:30 AM logoBruker and DECTRIS Announce Advances in D8™ X-ray Diffraction Systems with the New EIGER2 R 500K Detector - August 22 at 10:26 PM logoBruker Announces Novel D8 VENTURE BIOTOOLS™ for Advanced Structural Biology Research by X-Ray Crystallography - August 21 at 4:41 PM logoBruker debuts new crystallography tools; shares up 1% - August 21 at 12:13 PM logo Analysts Expect Bruker Corporation (BRKR) Will Announce Quarterly Sales of $414.24 Million - August 15 at 10:02 AM logoBruker Corporation (BRKR) Plans Quarterly Dividend of $0.04 - August 14 at 6:08 PM logoQ3 2017 EPS Estimates for Bruker Corporation Decreased by William Blair (NASDAQ:BRKR) - August 14 at 3:36 AM logoIHS Markit Score downgrades Bruker Corp to 63 out of 100, ranking positively in only one out of three available IHS Markit categories. - August 12 at 9:27 PM logoBruker Corp. – Value Analysis (NASDAQ:BRKR) : August 11, 2017 - August 11 at 10:10 PM logoFrank H. Laukien Acquires 2,335 Shares of Bruker Corporation (NASDAQ:BRKR) Stock - August 10 at 8:40 PM logoSee what the IHS Markit Score report has to say about Bruker Corp. - August 9 at 9:57 PM logoHungarian Ministry of Agriculture Selects Bruker NMR FoodScreener® for Authentication and Identification of Hungarian Wines - August 8 at 9:31 PM logoBruker Acquires Company XGLab with Unique X-Ray Detection Technologies and XRF Instruments for Art & Conservation Markets - August 7 at 5:16 PM logoBruker Corp. breached its 50 day moving average in a Bearish Manner : BRKR-US : August 7, 2017 - August 7 at 5:16 PM logoBruker Corporation to Post Q3 2017 Earnings of $0.26 Per Share, Jefferies Group Forecasts (BRKR) - August 7 at 8:08 AM logoBruker Corporation to Post Q3 2017 Earnings of $0.30 Per Share, Leerink Swann Forecasts (NASDAQ:BRKR) - August 7 at 8:08 AM logoEdited Transcript of BRKR earnings conference call or presentation 3-Aug-17 8:30pm GMT - August 4 at 10:01 PM logoBruker (BRKR) Q2 Earnings & Revenues Beat Estimates, View Up - August 4 at 5:00 PM logoBruker (BRKR) Q2 2017 Results - Earnings Call Transcript - August 3 at 11:12 PM logoBruker Corporation (NASDAQ:BRKR) Announces Quarterly Earnings Results, Beats Expectations By $0.03 EPS - August 3 at 8:09 PM logoBruker Corporation (NASDAQ:BRKR) Updates FY17 Earnings Guidance - August 3 at 6:24 PM logoBruker Reports Second Quarter 2017 Financial Results - August 3 at 6:11 PM logoBruker beats Street 2Q forecasts - August 3 at 6:11 PM logoBruker Announces Acquisition of Field-Portable Platform for Fast and Universal Immunoassay-Detection of Bacteria, Viruses and Toxins - August 2 at 5:27 PM logoReviewing Intuitive Surgical (ISRG) and Bruker Corporation (BRKR) - August 2 at 7:58 AM logoBruker Announces US FDA Clearance of Expanded 3rd Claim for MALDI Biotyper - July 31 at 4:45 PM logoBruker Announces New Starting Time for the Company's Second Quarter 2017 Earnings Conference Call and Webcast - July 31 at 4:45 PM logoFDA clears expanded claim for Bruker's microbial ID system; shares up 1% - July 31 at 12:40 PM



Bruker Corporation (BRKR) Chart for Saturday, October, 21, 2017

This page was last updated on 10/21/2017 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.